Literature DB >> 17508389

Oral vaccines: new needs, new possibilities.

Mohd Azhar Aziz1, Shuchi Midha, Syed Mohsin Waheed, Rakesh Bhatnagar.   

Abstract

Vaccination is an important tool for handling healthcare programs both in developed and developing countries. The current global scenario calls for a more-efficacious, acceptable, cost-effective and reliable method of immunization for many fatal diseases. It is hoped that the adoption of oral vaccines will help to provide an effective vaccination strategy, especially in developing countries. Mucosal immunity generated by oral vaccines can serve as a strong first line of defense against most of the pathogens infecting through the mucosal lining. Advances in elucidating the mechanism of action of oral vaccines will facilitate the design of more effective, new generation vaccines. There are promising developments in the use of different agents to effectively deliver the vaccine candidate. It is hoped that ongoing research may be able to set another cardinal point, after polio vaccine, in eradicating infectious diseases. (c) 2007 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17508389     DOI: 10.1002/bies.20580

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  10 in total

1.  Construction of a Lactobacillus plantarum Strain Expressing the Capsid Protein of Porcine Circovirus Type 2d (PCV2d) as an Oral Vaccine.

Authors:  Yi-Han Tseng; Cheng-Chu Hsieh; Tsun-Yung Kuo; Je-Ruei Liu; Ting-Yu Hsu; Shu-Chen Hsieh
Journal:  Indian J Microbiol       Date:  2019-10-23       Impact factor: 2.461

2.  Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a.

Authors:  Madushini N Dharmasena; Manuel Osorio; Kazuyo Takeda; Scott Stibitz; Dennis J Kopecko
Journal:  Clin Vaccine Immunol       Date:  2017-12-05

3.  Listeria monocytogenes delivery of HPV-16 major capsid protein L1 induces systemic and mucosal cell-mediated CD4+ and CD8+ T-cell responses after oral immunization.

Authors:  Waleed Mustafa; Paulo Cesar Maciag; Zhen-kun Pan; Jessica R Weaver; Yuhong Xiao; Stuart N Isaacs; Yvonne Paterson
Journal:  Viral Immunol       Date:  2009-06       Impact factor: 2.257

4.  Cloning and Expression of Gumboro VP2 Antigen in Aspergillus niger.

Authors:  Mohammad Azizi; Bagher Yakhchali; Abdolreza Ghamarian; Somayeh Enayati; Mahvash Khodabandeh; Vahid Khalaj
Journal:  Avicenna J Med Biotechnol       Date:  2013-01

5.  Low-dose oral immunization with lyophilized tissue of herbicide-resistant lettuce expressing hepatitis B surface antigen for prototype plant-derived vaccine tablet formulation.

Authors:  Tomasz Pniewski; Józef Kapusta; Piotr Bociąg; Jacek Wojciechowicz; Anna Kostrzak; Michał Gdula; Olga Fedorowicz-Strońska; Piotr Wójcik; Halina Otta; Sławomir Samardakiewicz; Bogdan Wolko; Andrzej Płucienniczak
Journal:  J Appl Genet       Date:  2010-11-23       Impact factor: 3.240

6.  Plant expression, lyophilisation and storage of HBV medium and large surface antigens for a prototype oral vaccine formulation.

Authors:  Tomasz Pniewski; Józef Kapusta; Piotr Bociąg; Anna Kostrzak; Olga Fedorowicz-Strońska; Marcin Czyż; Michał Gdula; Paweł Krajewski; Bogdan Wolko; Andrzej Płucienniczak
Journal:  Plant Cell Rep       Date:  2012-01-14       Impact factor: 4.570

7.  Preformulation studies with the Escherichia coli double mutant heat-labile toxin adjuvant for use in an oral vaccine.

Authors:  Jessica A White; Candace Haghighi; Johanna Brunner; Marcus Estrada; Manjari Lal; Dexiang Chen
Journal:  J Immunol Methods       Date:  2017-09-20       Impact factor: 2.303

8.  Elimination of persistent vaccine bacteria of Salmonella enterica serovar Typhimurium in the guts of immunized mice by inducible expression of truncated YncE.

Authors:  Yiran Wang; Jianhua Li; Kun Xiong; Zhijin Chen; Chunping Zheng; Yong Tan; Yanguang Cong
Journal:  PLoS One       Date:  2017-06-19       Impact factor: 3.240

9.  Thermoresponsive Bacteriophage Nanocarrier as a Gene Delivery Vector Targeted to the Gastrointestinal Tract.

Authors:  Katawut Namdee; Mattaka Khongkow; Suwimon Boonrungsiman; Naiyaphat Nittayasut; Paladd Asavarut; Sasithon Temisak; Nattika Saengkrit; Satit Puttipipatkhachorn; Amin Hajitou; Kiat Ruxrungtham; Teerapong Yata
Journal:  Mol Ther Nucleic Acids       Date:  2018-05-01       Impact factor: 8.886

10.  Immunogenicity of enterotoxigenic Escherichia coli outer membrane vesicles encapsulated in chitosan nanoparticles.

Authors:  Nafiseh Noroozi; Seyed Latif Mousavi Gargari; Shahram Nazarian; Samaneh Sarvary; Razieh Rezaei Adriani
Journal:  Iran J Basic Med Sci       Date:  2018-03       Impact factor: 2.699

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.